IT1398032B1 - Transferrina per il trattamento di malattie autoimmuni. - Google Patents

Transferrina per il trattamento di malattie autoimmuni.

Info

Publication number
IT1398032B1
IT1398032B1 ITFI2010A000020A ITFI20100020A IT1398032B1 IT 1398032 B1 IT1398032 B1 IT 1398032B1 IT FI2010A000020 A ITFI2010A000020 A IT FI2010A000020A IT FI20100020 A ITFI20100020 A IT FI20100020A IT 1398032 B1 IT1398032 B1 IT 1398032B1
Authority
IT
Italy
Prior art keywords
transferrina
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Application number
ITFI2010A000020A
Other languages
English (en)
Inventor
Filippo Mori
Ester Ascione
Ferdinando Nicoletti
Pierangelo Giovacchini
Original Assignee
Kedrion Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kedrion Spa filed Critical Kedrion Spa
Priority to ITFI2010A000020A priority Critical patent/IT1398032B1/it
Priority to PCT/IB2011/050623 priority patent/WO2011098990A1/en
Priority to HUE11711655A priority patent/HUE038120T2/hu
Priority to ES11711655.8T priority patent/ES2674326T3/es
Priority to US13/574,646 priority patent/US9138454B2/en
Priority to CA2787727A priority patent/CA2787727C/en
Priority to EP11711655.8A priority patent/EP2536419B1/en
Publication of ITFI20100020A1 publication Critical patent/ITFI20100020A1/it
Application granted granted Critical
Publication of IT1398032B1 publication Critical patent/IT1398032B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITFI2010A000020A 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni. IT1398032B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITFI2010A000020A IT1398032B1 (it) 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni.
PCT/IB2011/050623 WO2011098990A1 (en) 2010-02-15 2011-02-15 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
HUE11711655A HUE038120T2 (hu) 2010-02-15 2011-02-15 Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
ES11711655.8T ES2674326T3 (es) 2010-02-15 2011-02-15 Transferrina para su uso en el tratamiento y/o profilaxis de enfermedades autoinmunes
US13/574,646 US9138454B2 (en) 2010-02-15 2011-02-15 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
CA2787727A CA2787727C (en) 2010-02-15 2011-02-15 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
EP11711655.8A EP2536419B1 (en) 2010-02-15 2011-02-15 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI2010A000020A IT1398032B1 (it) 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni.

Publications (2)

Publication Number Publication Date
ITFI20100020A1 ITFI20100020A1 (it) 2011-08-16
IT1398032B1 true IT1398032B1 (it) 2013-02-07

Family

ID=42542741

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI2010A000020A IT1398032B1 (it) 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni.

Country Status (7)

Country Link
US (1) US9138454B2 (it)
EP (1) EP2536419B1 (it)
CA (1) CA2787727C (it)
ES (1) ES2674326T3 (it)
HU (1) HUE038120T2 (it)
IT (1) IT1398032B1 (it)
WO (1) WO2011098990A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
EP3318256A1 (en) 2016-11-08 2018-05-09 Quimatryx, S.L Compounds for the treatment of autoimmune diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0696455A1 (en) 1994-08-11 1996-02-14 Cellena (Cell Engineering) A.G. Transferrin compositions to alleviate the side effects of cytotoxic drugs
DE69527640T2 (de) 1994-11-10 2003-04-24 Cellena Ag, Ebmatingen Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
US5849293A (en) 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
US6126955A (en) 1998-04-16 2000-10-03 University Of Utah Research Foundation Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials
US6326473B1 (en) * 1998-12-30 2001-12-04 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US20070149440A1 (en) * 2005-12-28 2007-06-28 Essential Skincare, Llc Transferrin and transferrin-based compositions for diabetes treatment
ITLU20070009A1 (it) 2007-05-21 2008-11-22 Kedrion Spa Uso di transferrina per la preparazione di composizioni farmaceutiche utili per il trattamento di infezioni batteriche come coadiuvanti nella terapia antibiotica.
EA201071059A1 (ru) * 2008-03-11 2011-04-29 Лайвайонекс Инк. Способы и композиции для лечения воспаления и связанных с воспалением патологических состояний

Also Published As

Publication number Publication date
CA2787727C (en) 2018-08-21
CA2787727A1 (en) 2011-08-18
ITFI20100020A1 (it) 2011-08-16
HUE038120T2 (hu) 2018-09-28
ES2674326T3 (es) 2018-06-28
EP2536419A1 (en) 2012-12-26
WO2011098990A1 (en) 2011-08-18
US20120296071A1 (en) 2012-11-22
US9138454B2 (en) 2015-09-22
EP2536419B1 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
SMT201700021B (it) Metodi per il trattamento di malattie autoimmuni con antagonisti del dll4
SMT201600064B (it) Anticorpi per il trattamento di un cancro esprimente claudina 6
IT1401188B1 (it) Dispositivo medico per patologie colonproctologiche.
DK3124610T3 (da) Hbv-behandling
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
SMT201500142B (it) Procedimento per la purificazione di proteine
IT1404454B1 (it) Procedimento per la realizzazione di sbozzati per scatole su misura.
DK2590565T3 (da) Blodprøvetagning
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
EP2556161A4 (en) METHODS OF TREATING AUTOIMMUNE DISEASES
ITTO20110857A1 (it) Procedimento per la produzione di cicloesanonossina.
FR2965717B1 (fr) Fauteuil roulant
ITRM20120473A1 (it) Use of glycerophosphoinositols for the treatment of septic shock
DK2455064T3 (da) Indretning til behandling af periodontal sygdom
IT1398032B1 (it) Transferrina per il trattamento di malattie autoimmuni.
BR112012018395A2 (pt) retentor de glande
DK2531124T3 (da) Indretninger til behandling af hudlæsioner
FR2965715B1 (fr) Fauteuil roulant
EP2701702A4 (en) OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISEASES
ES1072600Y (es) Consolador sexual
IT1406405B1 (it) Molecole peptidiche per il trattamento di patologie mitocondriali
PL395785A1 (pl) Zastosowanie medyczne N-etylo-3-amino-4-fenylo-5-okso-2,5-dihydro-1H-pirazolo-1-karbotioamidu
TH137287B (th) สารชักนำอะพอพโทซิสสำหรับการรักษามะเร็งและโรคทางภูมิคุ้มกันและภูมิต้าน ตนเอง (Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases)
TH125899B (th) องค์ประกอบปฏิบัติต่อผิวหนัง